Appendix 3Y Change of Director’s Interest Notice + See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 1 Rule 3.19A.2 Appendix 3Y Change of Director’s Interest Notice Information or documents not available now must be given to ASX as soon as available. Information and...
Change of Director's Interest Notice
Filed with ASX · · 2 pages · English
Release
Argenica Therapeutics Ltd on 6ix
Earlier from Argenica Therapeutics
- AGM Date & Closing Date for Director Nominations
- Concussion Data Selected for Neurotrauma Congress
- Appendix 4E & Annual Report to 30 June 2026
- Appendix 4G & Corporate Governance Statement
- Notification of cessation of securities - AGN
Later from Argenica Therapeutics
- Notice of Annual General Meeting/Proxy Form
- New Mechanism Findings Offer Insights Into Phase 2 Signal
- Quarterly Activities/Appendix 4C Cash Flow Report
- Becoming a substantial holder
Follow Argenica Therapeutics into a list and get an email when it puts out news.
Follow Argenica Therapeutics